CannIntelligence open content

Florida bill will not distinguish delta-8 THC from other hemp-derived products

Written by Freddie Dawson | 16th December 2021

There are incorrect reports that a proposed bill in Florida would regulate delta-8 THC products in the state. In fact the bill will place limitations on the sale of all hemp-derived products ...

UK health trust teams up with Awakn to investigate psychedelic treatment

Written by Lorraine Mullaney | 13th December 2021

The UK’s National Health Service (NHS) has expressed some interest in the viability of psychedelics as a course of treatment ...

What do Luxembourg and Malta’s legal cannabis plans mean in practice?

Written by Freddie Dawson | 9th December 2021

Will proposed plans to legalise recreational cannabis in Luxembourg and Malta change much in terms of EU business? ...

Little stands in the way of Germany legalising recreational cannabis by 2024

Written by CannIntelligence | 30th November 2021

The incoming German ‘traffic light’ coalition government’s promise to legalise recreational cannabis for adults puts it on track to be the first major European nation to take such action ...

Podcast: A UK doctor’s take on CBD

Written by CBD-Intel | 25th November 2021

CBD-Intel podcast editor Jon Bruford meets Dr K CBD's Dr Ruchira Karunadasa who explains why he believes the company has an important role to play in helping the industry towards mature dialogue, and the impact...

New German coalition plans to legalise cannabis – but when will sales begin?

Written by Freddie Dawson | 25th November 2021

The newly elected German governing coalition has followed through on pre-election promises and included a plan for cannabis legalisation in its coalition agreement – but many questions remain to be answered ...

European Commission commentary on French CBD rules raises wider questions

Written by CannIntelligence | 19th November 2021

Questions on European policies banning flowers and outlining permitted THC levels in food ingredients have been raised by a commentary from the EC to a French proposal ...

Why are specialist vape retailers around the world turning away from CBD online?

Written by Freddie Dawson | 17th November 2021

More and more vape specialists appear to be moving away from selling CBD vaping products, according to online market data produced by CBD-Intel ...

Gupta’s appointment and nomination of Califf may indicate change in US climate

Written by Freddie Dawson | 16th November 2021

Rahul Gupta has been confirmed by the US Senate as director of National Drug Control Policy, while president Joe Biden intends to nominate Robert Califf as head of the US Food and Drug Administration (FDA)...

eBay prepares to take on Amazon with the launch of UK trial of CBD sales

Written by Freddie Dawson | 10th November 2021

eBay is set to launch a CBD trial, sources tell CBD-Intel. The internet marketplace that built its name as an auction site is said to be anticipating a November start for its UK...

The suspense continues, still with no end in sight to the UK’s novel food saga

Written by Freddie Dawson | 3rd November 2021

October has ended and November begun with still no further update from the UK Food Standards Agency (FSA) on the ongoing novel food application...

Concerns arise as Italian study finds pesticides and metals in hemp flowers

Written by CannIntelligence | 29th October 2021

Another study, this time from Italy, has found potentially dangerous levels of heavy metals and pesticides in CBD products. Researchers were worried by the results and asked regulators and legislators to act ...

Court of Cassation ruling spreads more confusion over French legal position

Written by CannIntelligence | 25th October 2021

The highest court in France has confirmed the decision made by the EU Court of Justice (CJEU) in the Kanavape case – but the decision has contributed to uncertainty over the legality of hemp-derived...

Brazilian report highlights theoretical growth but small current numbers

Written by CannIntelligence | 22nd October 2021

Interest in the Brazilian medical cannabinoid market is based on optimistic projections of growth continuing in the same vein rather than concrete current numbers, a domestic report has confirmed ...

US states fall over themselves backwards to sow further confusion over delta-8

Written by Anthony Traurig | 21st October 2021

A few US states may have over-corrected course in their rushing to modify regulations to cover hemp-derived delta-8 THC ...

Potential for psychedelic treatments prompts big North American buyouts

Written by Lorraine Mullaney | 15th October 2021

Interest in psychedelic drugs and treatments continues to grow, as evidenced by three major takeovers in Canada and the USA, two involving drug treatments developments and another offering a network of ketamine infusion treatment centres...

Charlotte’s Web new dietary ingredient application did include ValidCare data

Written by Freddie Dawson | 14th October 2021

It turns out the Charlotte’s Web application to the US FDA for the registration of a full spectrum hemp extract as a new dietary ingredient (NDI) DID include data from the ValidCare industry study ...

German medical cannabis imports rise but no sign of domestic production yet

Written by CannIntelligence | 8th October 2021

German imports of medical cannabis flowers rose by 80% in the first half of 2021 compared to the same period of 2021, but hopes of establishing local production were...

Could CBD companies face scrutiny from another US regulatory agency?

Written by Freddie Dawson | 6th October 2021

Does the CBD industry now face increased scrutiny from the US Securities and Exchange Commission (SEC)? ...

From craft beer to coffee, patience is a virtue in cannabinoid beverages

Written by Lorraine Mullaney | 4th October 2021

Patience continues to be the watchword when it comes to innovation in the cannabinoid beverage space. Developments continue but companies appear willing to take their time to enter the market as regulation loosens ...